CN111388565A - 一种提高母畜和幼畜造血功能的中药配方及其制备方法 - Google Patents
一种提高母畜和幼畜造血功能的中药配方及其制备方法 Download PDFInfo
- Publication number
- CN111388565A CN111388565A CN202010450007.9A CN202010450007A CN111388565A CN 111388565 A CN111388565 A CN 111388565A CN 202010450007 A CN202010450007 A CN 202010450007A CN 111388565 A CN111388565 A CN 111388565A
- Authority
- CN
- China
- Prior art keywords
- chinese medicine
- traditional chinese
- parts
- livestock
- improving
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 57
- 244000144972 livestock Species 0.000 title claims abstract description 35
- 238000002360 preparation method Methods 0.000 title claims abstract description 9
- 230000011132 hemopoiesis Effects 0.000 title claims description 10
- 239000000843 powder Substances 0.000 claims abstract description 25
- 238000004880 explosion Methods 0.000 claims abstract description 24
- 235000019764 Soybean Meal Nutrition 0.000 claims abstract description 17
- 239000004455 soybean meal Substances 0.000 claims abstract description 17
- 239000002994 raw material Substances 0.000 claims abstract description 13
- LPOSZYSKJWFIQH-UHFFFAOYSA-N 2-aminoacetic acid;iron Chemical compound [Fe].NCC(O)=O LPOSZYSKJWFIQH-UHFFFAOYSA-N 0.000 claims abstract description 7
- 241001465754 Metazoa Species 0.000 claims description 10
- AKLSSKNRPSKJBO-UHFFFAOYSA-K 2-aminoacetate;iron(3+) Chemical compound [Fe+3].NCC([O-])=O.NCC([O-])=O.NCC([O-])=O AKLSSKNRPSKJBO-UHFFFAOYSA-K 0.000 claims description 9
- 241000132012 Atractylodes Species 0.000 claims description 6
- 241000405414 Rehmannia Species 0.000 claims description 6
- 241000382455 Angelica sinensis Species 0.000 claims description 5
- 241000112528 Ligusticum striatum Species 0.000 claims description 5
- 239000000463 material Substances 0.000 claims description 4
- 239000012467 final product Substances 0.000 claims description 3
- 238000002156 mixing Methods 0.000 claims description 3
- 238000004806 packaging method and process Methods 0.000 claims description 3
- 238000005422 blasting Methods 0.000 claims description 2
- 238000010298 pulverizing process Methods 0.000 claims description 2
- 210000004369 blood Anatomy 0.000 abstract description 11
- 239000008280 blood Substances 0.000 abstract description 11
- 230000003394 haemopoietic effect Effects 0.000 abstract description 7
- 208000007502 anemia Diseases 0.000 abstract description 5
- 230000003213 activating effect Effects 0.000 abstract description 4
- 230000008901 benefit Effects 0.000 abstract description 4
- 229940079593 drug Drugs 0.000 abstract description 3
- 230000036039 immunity Effects 0.000 abstract description 3
- 208000035240 Disease Resistance Diseases 0.000 abstract description 2
- 230000000857 drug effect Effects 0.000 abstract description 2
- 239000004480 active ingredient Substances 0.000 abstract 1
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 12
- 229910052742 iron Inorganic materials 0.000 description 6
- 210000000952 spleen Anatomy 0.000 description 6
- 208000002193 Pain Diseases 0.000 description 5
- 230000007812 deficiency Effects 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 230000036407 pain Effects 0.000 description 5
- 208000024891 symptom Diseases 0.000 description 5
- 244000068988 Glycine max Species 0.000 description 4
- 235000010469 Glycine max Nutrition 0.000 description 4
- 238000009395 breeding Methods 0.000 description 4
- 230000001488 breeding effect Effects 0.000 description 4
- 208000004998 Abdominal Pain Diseases 0.000 description 3
- 201000000736 Amenorrhea Diseases 0.000 description 3
- 206010001928 Amenorrhoea Diseases 0.000 description 3
- 206010007247 Carbuncle Diseases 0.000 description 3
- 231100000540 amenorrhea Toxicity 0.000 description 3
- 230000009286 beneficial effect Effects 0.000 description 3
- 230000001502 supplementing effect Effects 0.000 description 3
- 206010007882 Cellulitis Diseases 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- 208000005171 Dysmenorrhea Diseases 0.000 description 2
- 206010013935 Dysmenorrhoea Diseases 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 206010019233 Headaches Diseases 0.000 description 2
- 208000019255 Menstrual disease Diseases 0.000 description 2
- 206010027514 Metrorrhagia Diseases 0.000 description 2
- 206010042674 Swelling Diseases 0.000 description 2
- 208000025865 Ulcer Diseases 0.000 description 2
- 208000022531 anorexia Diseases 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 206010061428 decreased appetite Diseases 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 208000002173 dizziness Diseases 0.000 description 2
- 208000001848 dysentery Diseases 0.000 description 2
- 201000006549 dyspepsia Diseases 0.000 description 2
- 208000010515 dystocia Diseases 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 231100000869 headache Toxicity 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 231100000397 ulcer Toxicity 0.000 description 2
- GIPOFCXYHMWROH-UHFFFAOYSA-L 2-aminoacetate;iron(2+) Chemical compound [Fe+2].NCC([O-])=O.NCC([O-])=O GIPOFCXYHMWROH-UHFFFAOYSA-L 0.000 description 1
- 206010000060 Abdominal distension Diseases 0.000 description 1
- 206010000242 Abortion threatened Diseases 0.000 description 1
- 206010049589 Afterbirth pain Diseases 0.000 description 1
- TWCMVXMQHSVIOJ-UHFFFAOYSA-N Aglycone of yadanzioside D Natural products COC(=O)C12OCC34C(CC5C(=CC(O)C(O)C5(C)C3C(O)C1O)C)OC(=O)C(OC(=O)C)C24 TWCMVXMQHSVIOJ-UHFFFAOYSA-N 0.000 description 1
- 241000125175 Angelica Species 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- PLMKQQMDOMTZGG-UHFFFAOYSA-N Astrantiagenin E-methylester Natural products CC12CCC(O)C(C)(CO)C1CCC1(C)C2CC=C2C3CC(C)(C)CCC3(C(=O)OC)CCC21C PLMKQQMDOMTZGG-UHFFFAOYSA-N 0.000 description 1
- 206010006895 Cachexia Diseases 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 206010055690 Foetal death Diseases 0.000 description 1
- 235000001287 Guettarda speciosa Nutrition 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010021118 Hypotonia Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 208000015710 Iron-Deficiency Anemia Diseases 0.000 description 1
- 208000037093 Menstruation Disturbances Diseases 0.000 description 1
- 206010027339 Menstruation irregular Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 206010033799 Paralysis Diseases 0.000 description 1
- 241000013557 Plantaginaceae Species 0.000 description 1
- 208000005374 Poisoning Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 206010041497 Spermatorrhoea Diseases 0.000 description 1
- 208000005985 Threatened Abortion Diseases 0.000 description 1
- 206010053476 Traumatic haemorrhage Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- 208000019790 abdominal distention Diseases 0.000 description 1
- 206010000210 abortion Diseases 0.000 description 1
- 231100000176 abortion Toxicity 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 239000003674 animal food additive Substances 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 210000000038 chest Anatomy 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 230000013872 defecation Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 208000026500 emaciation Diseases 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 230000012173 estrus Effects 0.000 description 1
- 206010016256 fatigue Diseases 0.000 description 1
- 208000017561 flaccidity Diseases 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 125000003147 glycosyl group Chemical group 0.000 description 1
- 238000009499 grossing Methods 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 210000002216 heart Anatomy 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- PFOARMALXZGCHY-UHFFFAOYSA-N homoegonol Natural products C1=C(OC)C(OC)=CC=C1C1=CC2=CC(CCCO)=CC(OC)=C2O1 PFOARMALXZGCHY-UHFFFAOYSA-N 0.000 description 1
- 235000020256 human milk Nutrition 0.000 description 1
- 210000004251 human milk Anatomy 0.000 description 1
- 208000006278 hypochromic anemia Diseases 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 210000000754 myometrium Anatomy 0.000 description 1
- 230000036565 night sweats Effects 0.000 description 1
- 206010029410 night sweats Diseases 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 230000032696 parturition Effects 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000001850 reproductive effect Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 238000010025 steaming Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 230000008736 traumatic injury Effects 0.000 description 1
- 230000010415 tropism Effects 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/26—Iron; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/236—Ligusticum (licorice-root)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/284—Atractylodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/80—Scrophulariaceae (Figwort family)
- A61K36/804—Rehmannia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B02—CRUSHING, PULVERISING, OR DISINTEGRATING; PREPARATORY TREATMENT OF GRAIN FOR MILLING
- B02C—CRUSHING, PULVERISING, OR DISINTEGRATING IN GENERAL; MILLING GRAIN
- B02C19/00—Other disintegrating devices or methods
- B02C19/18—Use of auxiliary physical effects, e.g. ultrasonics, irradiation, for disintegrating
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/10—Preparation or pretreatment of starting material
- A61K2236/15—Preparation or pretreatment of starting material involving mechanical treatment, e.g. chopping up, cutting or grinding
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Toxicology (AREA)
- Food Science & Technology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种提高母畜和幼畜造血功能的中药配方及其制备方法，用于提高母畜和幼畜的造血功能，属于兽药技术领域，该中药配方，按重量份计，其原料成分包括：气爆中药粉20～30份、甘氨酸铁20～30份和烘焙大豆粉30～50份；本发明的中药配方具药效作用迅速、有效成分含量高、释放快的优点，能够起到很好的益气活血、防治贫血、提升机体免疫力和抗病力的功效。
Description
技术领域
一种提高母畜和幼畜造血功能的中药配方及其制备方法，属于兽药技术领域，尤其涉及提高造血功能药物技术领域。
背景技术
目前，规模化、标准化的养殖业中，畜类养殖方式多采用限位饲养的方式，导致畜类活动空间狭小，尤其对于母畜在妊娠后期长期卧地，运动范围狭小，导致母畜严重贫血，分娩时子宫肌收缩无力，产程长，一方面容易导致死胎、弱仔，另一方面引起难产或母畜元气过度损伤、气虚血亏，并发炎症，产后恢复慢，发情困难、淘汰率增高。
幼畜在断奶前其营养全部或部分由母乳提供，因此，母畜的健康状况也直接影响着幼畜的生长发育；幼畜断奶前后处于体重高速增长期，仅仅通过饲料补充铁元素很难达到需求，幼畜出现贫血会出现食欲减退、生长缓慢，倦怠喜卧，体弱、被毛皮肤粗糙、黏膜苍白或黄染、严重的可引发呼吸困难等症状，同时对某些传染病抵抗力降低。
因此，无论是母畜还是幼畜，补充充足的铁，提高其造血功能，对于降低养殖成本，提高畜类生长和生殖性能具有十分重要的现实意义。
发明内容
本发明的目的在于：提供一种提高母畜和幼畜造血功能的中药配方及其制备方法，具药效作用迅速、有效成分含量高、释放快的优点，能够起到很好的益气活血、防治贫血、提升机体免疫力和抗病力的功效。
本发明采用的技术方案如下：
为实现上述目的，本发明提供一种提高母畜和幼畜造血功能的中药配方，按重量份计，其原料成分包括：气爆中药粉20～30份、甘氨酸铁20～30份和烘焙大豆粉30～50份。
作为优选，所述中药配方按重量份计，其原料成分包括：气爆中药粉30份、甘氨酸铁30份和烘焙大豆粉40份。
作为优选，所述气爆中药粉包括：当归、熟地、白术和川芎。
当归，性味，甘、辛、温；归经，归肝、心、脾经；功能主治，补血；活血；调经止痛；润燥滑肠。主血虚诸证；月经不调；经闭；痛经；症瘕结聚；崩漏；虚寒腹痛；痿痹；肌肤麻木；肠燥便难；赤痢后重；痈疽疮疡；跌扑损伤。
熟地又名熟地黄或伏地，属玄参科植物，是一种上好中药材，具有补血滋阴功效，可用于血虚萎黄，眩晕，心悸失眠，月经不调，崩漏等症，亦可用于肾阴不足的潮热骨蒸、盗汗、遗精、消渴等症。
白术，苦、甘，温。健脾益气，燥湿利水，止汗，安胎。用于脾虚食少，消化不良，泄泻，水肿，自汗，胎动不安。
川芎，性味，辛，温；归经，入肝、胆经；功能主治，行气开郁，法风燥湿，活血止痛。治风冷头痛旋晕，胁痛腹疼，寒痹筋挛，经闭，难产，产后瘀阻块痛，痈疽疮疡。用于月经不调，经闭痛经，瘕腹痛，胸胁刺痛，跌扑肿痛，头痛，风湿痹痛。
烘焙大豆粉，具有健脾益气宽中、润燥消水等作用，可用于脾气虚弱、消化不良、疳积泻痢、腹胀赢瘦、妊娠中毒、疮痈肿毒、外伤出血等症；大豆含有大量的不饱和脂肪酸，多种微量元素、维生素及优质蛋白质，是高血压、动脉硬化、心脏病等心血管病人的有益食品；大豆中所含的铁，不仅量多，且容易被吸收，对生长发育及缺铁性贫血具有很大益处。
作为优选，所述气爆中药粉中，当归、熟地、白术和川芎的质量比为1：3：3：3。
本发明还提供一种提高母畜和幼畜造血功能的中药配方的制备方法，包括以下步骤：
(1)将中药粉碎，放入气爆机，通空气压力为0.8MPa，然后迅速通入1.5MPa蒸汽，保压3min后泄压爆破得气爆中药粉，备用；
(2)向气爆中药粉中加入甘氨酸铁和烘焙大豆粉，混合均匀，包装，即得成品。
作为优选，所述中药粉碎至50～100目。
综上所述，由于采用了上述技术方案，本发明的有益效果是：
1.本发明选用当归、熟地、白术和川芎作为中药成分，具有很好的补血活血功效，配以白术健脾益气，加入甘氨酸铁补充铁元素提高血红蛋白含量、促进红细胞生长，提高免疫力，同时烘焙大豆粉进一步提供铁元素，共同起到很好的益气活血、防治贫血、提升机体免疫力和抗病力的功效。
2.本发明中药采用气爆中药，通过气爆处理打破中药植物细胞壁的屏障结构，有利于有效成分的释放和提取，气爆过程中物料自体水解发生去糖苷化作用使天然植物中的苷元与糖基分离，提高苷类物质提取和分离效率，气爆处理中药具有高效快速和避免有效成分流失的优点，提高了中药有效成分的利用率。
具体实施方式
下面对本发明的技术方案进行清楚、完整地描述，显然，所描述的实施例仅仅是本发明一部分实施例，而不是全部的实施例。基于本发明中的实施例，本领域普通技术人员在没有做出创造性劳动前提下所获得的所有其他实施例，都属于本发明保护的范围。
实施例1
本实施例提供一种提高母畜和幼畜造血功能的中药配方，按重量份计，其原料成分包括：气爆中药粉20份、甘氨酸铁30份和烘焙大豆粉40份。
本实施例还提供该中药配方的制备方法，包括以下步骤：
(1)将中药粉碎至50～100目，放入气爆机，通空气压力为0.8MPa，然后迅速通入1.5MPa蒸汽，保压3min后泄压爆破得气爆中药粉，备用；
(2)向气爆中药粉中加入甘氨酸铁和烘焙大豆粉，混合均匀，包装，即得成品。
实施例2
本实施例于实施例1的不同之处在于，所述的中药配方，按重量份计，其原料成分包括：气爆中药粉30份、甘氨酸铁30份和烘焙大豆粉40份。
实施例3
本实施例于实施例1的不同之处在于，所述的中药配方，按重量份计，其原料成分包括：气爆中药粉30份、甘氨酸铁20份和烘焙大豆粉50份。
实施例4
本实施例于实施例1的不同之处在于，所述的中药配方，按重量份计，其原料成分包括：气爆中药粉30份、甘氨酸铁30份和烘焙大豆粉50份。
实施例5
本实施例于实施例1的不同之处在于，所述的中药配方，按重量份计，其原料成分包括：气爆中药粉20份、甘氨酸铁20份和烘焙大豆粉30份。
实施例6
本实施例于实施例1的不同之处在于，所述的中药配方，按重量份计，其原料成分包括：气爆中药粉25份、甘氨酸铁30份和烘焙大豆粉45份。
实施例7
本实施例于实施例1的不同之处在于，所述的中药配方，按重量份计，其原料成分包括：气爆中药粉30份、甘氨酸铁25份和烘焙大豆粉40份。
实施例8
本实施例于实施例1的不同之处在于，所述的中药配方，按重量份计，其原料成分包括：气爆中药粉25份、甘氨酸铁25份和烘焙大豆粉45份。
最后应说明的是：以上实施例仅用以说明本发明的技术方案，而非对其限制；尽管参照前述实施例对本发明进行了详细的说明，本领域的普通技术人员应当理解：其依然可以对前述实施例所记载的技术方案进行修改，或者对其中部分或者全部技术特征进行等同替换；而这些修改或者替换，并不使相应技术方案的本质脱离本发明实施例技术方案的范围，其均应涵盖在本发明的权利要求和说明书的范围当中。
Claims (6)
1.一种提高母畜和幼畜造血功能的中药配方，其特征在于，按重量份计，其原料成分包括：气爆中药粉20～30份、甘氨酸铁20～30份和烘焙大豆粉30～50份。
2.一种提高母畜和幼畜造血功能的中药配方，其特征在于，按重量份计，其原料成分包括：气爆中药粉30份、甘氨酸铁30份和烘焙大豆粉40份。
3.根据权利要求1所述的一种提高母畜和幼畜造血功能的中药配方，其特征在于，所述气爆中药粉包括：当归、熟地、白术和川芎。
4.根据权利要求3所述的一种提高母畜和幼畜造血功能的中药配方，其特征在于，所述气爆中药粉中，当归、熟地、白术和川芎的质量比为1：3：3：3。
5.基于权利要求1～4任一项所述的一种提高母畜和幼畜造血功能的中药配方的制备方法，其特征在于，包括以下步骤：
(1)将中药粉碎，放入气爆机，通空气压力为0.8MPa，然后迅速通入1.5MPa蒸汽，保压3min后泄压爆破得气爆中药粉，备用；
(2)向气爆中药粉中加入甘氨酸铁和烘焙大豆粉，混合均匀，包装，即得成品。
6.根据权利要求5所述的一种提高母畜和幼畜造血功能的中药配方的制备方法，其特征在于，所述中药粉碎至50～100目。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010450007.9A CN111388565A (zh) | 2020-05-25 | 2020-05-25 | 一种提高母畜和幼畜造血功能的中药配方及其制备方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010450007.9A CN111388565A (zh) | 2020-05-25 | 2020-05-25 | 一种提高母畜和幼畜造血功能的中药配方及其制备方法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN111388565A true CN111388565A (zh) | 2020-07-10 |
Family
ID=71411937
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202010450007.9A Pending CN111388565A (zh) | 2020-05-25 | 2020-05-25 | 一种提高母畜和幼畜造血功能的中药配方及其制备方法 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN111388565A (zh) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111887350A (zh) * | 2020-08-17 | 2020-11-06 | 上海申亚动物保健品阜阳有限公司 | 一种促生长提高抵抗力的发酵中药饲料添加剂及其制备方法 |
| CN114343057A (zh) * | 2022-01-11 | 2022-04-15 | 山东迅达康兽药有限公司 | 一种补血用饲料添加剂及其制备方法 |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109258947A (zh) * | 2018-09-21 | 2019-01-25 | 山东亚华生物科技有限公司 | 一种用于仔猪补血的复方制剂 |
-
2020
- 2020-05-25 CN CN202010450007.9A patent/CN111388565A/zh active Pending
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109258947A (zh) * | 2018-09-21 | 2019-01-25 | 山东亚华生物科技有限公司 | 一种用于仔猪补血的复方制剂 |
Non-Patent Citations (3)
| Title |
|---|
| 张亚微: "猪场贫血的预防措施", 《北方牧业》 * |
| 张伯礼等: "《中药现代化二十年：1996-2015》", 31 October 2016, 上海科学技术出版社 * |
| 湖南省革委会农林局: "《兽医手册》", 30 April 1972, 湖南人民出版社 * |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111887350A (zh) * | 2020-08-17 | 2020-11-06 | 上海申亚动物保健品阜阳有限公司 | 一种促生长提高抵抗力的发酵中药饲料添加剂及其制备方法 |
| CN111887350B (zh) * | 2020-08-17 | 2023-12-26 | 上海申亚动物保健品阜阳有限公司 | 一种促生长提高抵抗力的发酵中药饲料添加剂及其制备方法 |
| CN114343057A (zh) * | 2022-01-11 | 2022-04-15 | 山东迅达康兽药有限公司 | 一种补血用饲料添加剂及其制备方法 |
| CN114343057B (zh) * | 2022-01-11 | 2023-08-29 | 山东迅达康兽药有限公司 | 一种补血用饲料添加剂及其制备方法 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1813853B (zh) | 母猪用中草药催乳剂及其制备方法 | |
| CN104873763A (zh) | 一种调理气虚体质的保健品 | |
| CN104783003A (zh) | 用于小猪的中草药全价饲料及其制备方法 | |
| CN111388565A (zh) | 一种提高母畜和幼畜造血功能的中药配方及其制备方法 | |
| CN104938956A (zh) | 一种健脑益智的营养麦片及其制作方法 | |
| CN106036059A (zh) | 一种提高牛肉品质的肉牛用中药饲料添加剂 | |
| CN102743657B (zh) | 防治仔猪腹泻病的中药物组合物及其制备方法 | |
| CN102919620A (zh) | 促进母猪发情的组合物及其饲料和应用 | |
| CN108403903A (zh) | 一种母猪催情散 | |
| CN107198022A (zh) | 提高空怀母猪断奶发情率和配种分娩率的预混合饲料及其制备方法 | |
| CN109602815A (zh) | 一种缩短母猪产程的补血组合物及其制备方法 | |
| CN107950795A (zh) | 一种用于促进仔猪快速生长的绿色健康饲料及其制备方法 | |
| CN108434308A (zh) | 促进母兔发情、提高受胎率的饲料添加剂及其制备方法 | |
| CN108522888A (zh) | 一种促雏鸡生长、提高蛋鸡产蛋率的饲料及其制备方法 | |
| CN113662099A (zh) | 一种提升高原地区荷斯坦奶牛繁殖力的饲料添加剂及应用 | |
| CN105797112A (zh) | 一种具有缓释效果的治疗母猪子宫炎的饲料添加剂 | |
| CN112369513A (zh) | 一种林麝中草药舔砖及其制备方法 | |
| CN106107069A (zh) | 一种空怀母牛用饲料及其制备方法 | |
| CN104491649A (zh) | 一种促进母猪发情提高产仔率及催乳功能的中药制剂 | |
| CN111228313A (zh) | 一种多功效梅花鹿丸及其制作方法 | |
| CN108432958A (zh) | 一种猪饲料添加剂 | |
| CN108552432A (zh) | 一种提高蛋鸡产蛋率的蛋鸡饲料及其制备方法 | |
| AU2021102946A4 (en) | Chinese Herbal Medicine Complete Feed for Piglets and Preparation Method Thereof | |
| CN103735713B (zh) | 一种改善营养性贫血的中药组合物及其制备方法 | |
| CN103479881B (zh) | 治疗肉仔鸡腹水综合征的纯中药组合物及其制备方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20200710 |
|
| RJ01 | Rejection of invention patent application after publication |